Hoffmann-La Roche Limited (Roche Canada) is proud to announce that Health Canada has granted market authorization for TNKase® ...

Expedited Development Enabled by RMAT and Breakthrough Therapy StatusClinical Trial Initiation in 2026, FDA Approval Target ...

Canada: The study indicates that botulinum toxin ( BTX) is a safe and effective adjunct treatment for refractory ischemic ...

Health Canada recently approved the injection treatment for acute ischemic stroke in adults, the first stroke medicine ...

BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has completed a third preliminary ...

Brainomix 360 Stroke imaging was utilized to improve and standardize the grading of baseline stroke severity, prior to ...

With well-defined targets and clear mechanism of action, Y-3 for Injection is able to exert multiple therapeutic effects. As the world’s first brain cytoprotectant developed based on the important ...

Researchers have developed a novel "theragnostic" approach for ischemic stroke using extracellular vesicles derived from human exfoliated deciduous teeth stem cells (SHED-EVs). Engineered with quantum ...

Healios KK ( ($JP:4593) ) has issued an update. Healios KK announced its development policy for HLCM051, prioritizing its use as a treatment for ...

Recently reported findings indicate that cenegermin-bkbj ophthalmic solution (Oxervate; Dompé) may perform as an effective ...

Southwest Research Institute (SwRI) and Trinity University will improve a prodrug, a compound activated in the body, to mitigate tissue and organ damage associated with heart attacks, strokes and ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...